Group 1 - The core viewpoint of the news is that Shandong Boyuan Pharmaceutical Chemical Co., Ltd. has seen a stock price increase of 5.04%, reaching 87.39 yuan per share, with a total market capitalization of 11.679 billion yuan [1] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane, and also engages in resource recycling [1] - The main business revenue composition includes iodides at 74.56%, specialty functional chemicals at 12.79%, trading business at 9.94%, and others at 2.72% [1] Group 2 - Among the top circulating shareholders of Boyuan, Penghua Fund has a fund, Penghua Huizhi Optimal Mixed A, which entered the top ten shareholders in the third quarter, holding 434,200 shares, accounting for 1.3% of circulating shares [2] - The fund has a total scale of 3.828 billion yuan, with a year-to-date return of 2.46% and a one-year return of 30.27% [2] - The fund manager Liang Hao has a tenure of 14 years and 181 days, with the best fund return during his tenure being 317.53% [3]
博苑股份股价涨5.04%，鹏华基金旗下1只基金位居十大流通股东，持有43.42万股浮盈赚取181.95万元